Literatur-DB: [Immunotherapy for esophageal carcinoma].
| Titel: | [Immunotherapy for esophageal carcinoma]. |
| Kategorien: | Ösophaguskarzinom |
| BuchID: | 146 |
| Autor: | Yamana, H |
| ISBN-10(13): | KA |
| Publikationsdatum: | 2002 04 |
| Number of pages: | 0 |
| Sprache: | Nicht spezifiziert |
| Preis: | 0.00 |
| Bewertung: |
|
| Bild: |
zum Original
|
| Beschreibung: |
AbstractRecent progress in gene technology has clarified the existence of some cancer-rejection genes and peptides such as MAGE, MART, etc. Many clinical trials with cancer vaccines have been performed. Since the clinical efficacy of HLA class I-restricted peptide vaccines is still poor, many researchers are mainly administering dendritic cell therapies. However, there have been few clinicals trials of cancer-specific immunotherapy for esophageal carcinomas. Artikel-Nr.: 103(4):376-80 | PubMed-ID: 11993228 | DOI: | ISBN: |
Rezensionen
